Bio Tech company, Celtrion to produce AIDS vaccines.

Published: 2003-02-28 06:57:00

Updated: 2003-02-28 06:57:00

Celtrion, a joint venture company between American VaxGen Inc. and other Korean investors, announced on Feb. 25 that they would construct a production facility at Songdo, a new town in Incheon for the production of bio-science related products including AIDS vaccine "Aidsvax" with capacity of ove...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK